| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |